4 93

한국인에서 chemokine 수용체(CCR5) promoter 유전자 다형성과 B형간염 바이러스 감염 후 임상 경과와의 상관성

Other Titles
 Association between CCR5 Promoter Polymorphisms and Hepatitis B Virus Infection 
Authors
 장혜영  ;  안상훈  ;  김도영  ;  신전수  ;  김용수  ;  홍선표  ;  정현재  ;  김수옥  ;  유왕돈  ;  한광협 
Citation
 Korean Journal of Hepatology (대한간학회지), Vol.11(2) : 116-124, 2005 
Journal Title
 Korean Journal of Hepatology (대한간학회지) 
ISSN
 1738-222X 
Issue Date
2005
Abstract
Background/Aims: Immunogenetic factors may play a role in determining the susceptibility of an individual to viral infection. CCR5 promoter polymorphisms are known to be associated with HIV infection. However, there has been no report on the association between CCR5 promoter polymorphism and HBV infection. Therefore, we investigated the relationship between the CCR5 promoter polymorphism and HBV infection. Methods: A total of 377 patients were classified into two groups according to their HBV infection status: ① the spontaneous clearance group (SC); HBsAg (-), anti-HBc (+), anti-HBs (+) ② the chronic HBsAg (+) carrier group (CC); HBsAg (+), anti-HBc (+), anti-HBs (-). CCR5 polymorphisms were detected by employing matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS)-based SNP scoring assay, termed Restriction Fragment Mass Polymorphism (RFMP), which exploits the differences in molecular masses between the common allele and rare allele bases of interest. Results: We found that the genotype frequencies of CCR5 A59029G significantly differed between the SC group (n=138) and CC group (n=239) (P<0.05). The CCR5 59029A allelic genotype was associated with an increased risks of chronic infection rather than spontaneous clearance (P=0.002), and the presence of the CCR5 59029G allele was significantly associated with the spontaneous clearance of HBV (P=0.001). Strong linkage disequilibrium between the CCR5-59029 and the CCR5-59353 polymorphic variants was identified. None of the 377 subjects had the CCR5-32 bp deletion mutation. Conclusions: The CCR5 promoter polymorphisms at position 59029 might play a role in the clearance of HBV infection. This primary experimental evidence needs further studies to clarify the clinical usefulness of CCR5 promoter polymorphisms as a target for the screening or treatment of HBV infection.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/150865
Files in This Item:
T200500991.pdf Download
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원)
Yonsei Authors
김도영(Kim, Do Young)
김용수(Kim, Yong Soo)
신전수(Shin, Jeon Soo) ORCID logo https://orcid.org/0000-0002-8294-3234
안상훈(Ahn, Sang Hoon)
장혜영(Chang, Hye Young)
한광협(Han, Kwang Hyup)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse